Abstract:Chengwu Gong, 1, * Jiyuan Ai, 1, * Yun Fan, 2 Jun Gao, 1 Weiwei Liu, 1 Qian Feng, 3 Wenjun Liao, 1 Linquan Wu 1 1 Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, People's Republic of China; 2 Department of Neurology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430000, People's Republic of China; 3 Department of Emergency Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, People's Republic of China *These authors contributed equally to this work Correspondence: Linquan Wu; Wenjun Liao Department of General Surgery, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Nanchang 330006, People's Republic of China Tel +86 791 86311529 Fax +86 791 86262262 Email wulqnc@163.com; liaowenjun120@163.com Purpose: Studies show that high expression of non-SMC condensin I complex subunit G (NCAPG) is associated with many tumors. In this study, we explore the mechanism by which NCAPG promotes proliferation in hepatocellular carcinoma (HCC). Patients and methods: Liver cancer and paracancerous tissue specimens of 90 HCC patients were collected, and expression levels of NCAPG in these tissues and cell lines were evaluated by Western blotting and immunohistochemistry. HCC cells were transfected with siRNAs and plasmids, and pathway activators or inhibitors were added. The 5-ethynyl-2ʹ-deoxyuridine (EdU) proliferation assay was used to measure cell proliferation. Flow cytometry was used to evaluate cell apoptosis. Western blot assays were performed as a standard procedure to detect total protein expression. Treated HCC cells were subcutaneously injected into nude mice. Results: Analysis using the Oncomine database showed that NCAPG was upregulated in HCC and immunohistochemistry and Western blot assays showed it was upregulated in both HCC tissues and HCC cell lines. The overexpression of NCAPG could promote HCC cell proliferation and reduce HCC cell apoptosis. More importantly, RNA-sequencing analysis predicted that NCAPG plays a role in the HCC via PI3K-AKT signaling pathway. The PI3K/AKT/FOXO4 pathway was aberrantly activated, and the expressions of apoptosis-related protein were altered when NCAPG was overexpressed or silenced both in vitro and in vivo. LY294002, a PI3K inhibitor, could eliminate the NCAPG role of promoting HCC cell proliferation and reducing HCC cell apoptosis, while 740Y-P, a PI3K activator, contributed to the opposite effect. Conclusion: NCAPG functions as an oncogene in HCC and plays a role in promoting cell proliferation and antiapoptosis through activating the PI3K/AKT/FOXO4 pathway. Keywords: NCAPG, hepatocellular carcinoma, PI3K/AKT, FOXO4, proliferation

The PI3K‐Akt Pathway Regulates Calpain 6 Expression, Proliferation, and Apoptosis

Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1

Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway

Caspase-6 is a Key Regulator of Cross-Talk Signal Way in PANoptosis in Cancer

NLRP6 potentiates PI3K/AKT signalling by promoting autophagic degradation of p85α to drive tumorigenesis

Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

Calpain 6 Inhibits Autophagy in Inflammatory Environments: A Preliminary Study on Myoblasts and a Chronic Kidney Disease Rat Model.

Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells

AKT activation controls cell survival in response to HDAC6 inhibition

Calpain 2 Knockdown Promotes Cell Apoptosis and Restores Gefitinib Sensitivity Through Epidermal Growth Factor Receptor/protein Kinase B/survivin Signaling.

PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival

Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer

COP9 signalosome subunit 6 mediates PDGF -induced pulmonary arterial smooth muscle cells proliferation.

A Novel Mechanism for P53 to Regulate Its Target Gene ECK in Signaling Apoptosis

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling

Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling Through TRIM24 Binding.

The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma

NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway

PAK6 promotes cervical cancer progression through activation of the Wnt/β-catenin signaling pathway

Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway